­
­
­
­

Inventi Impact - Cardiology & Haematology
(Formerly Inventi Rapid/Impact: Blood)

Patent Watch

  • METHOD AND APPARATUS FOR PERCUTANEOUS TREATMENT OF A BLOOD VESSEL

    Method and apparatus for percutaneous repair of an affected area in a blood vessel.

  • CHOLESTEROL LOWERING AGENT, NEUTRAL FAT LOWERING AGENT, BLOOD GLUCOSE LEVEL LOWERING AGENT, CHOLESTEROL ADSORBENT, ADSORBENT, NEUTRAL FAT ADSORBENT, HEALTHY FOOD, HEALTH SUPPLEMENT, FOOD WITH NUTRIENT FUNCTION CLAIMS, FOOD FOR SPECIFIED HEALTH USE, QUASI-DRUG, AND PHARMACEUTICAL DRUG

    [Object] To provide a cholesterol lowering agent, a neutral fat lowering agent, a blood glucose level lowering agent, a cholesterol adsorbent, and a neutral fat adsorbent, which have high safety. [Solving Means] A cholesterol lowering agent, a neutral fat lowering agent, a blood glucose level lowering agent, a cholesterol adsorbent, and a neutral fat adsorbent include a porous carbon material having a specific surface area value of 10 m.sup.2/g or more and a pore volume of 0.1 cm.sup.3/g or more, the specific surface area value being measured by a nitrogen BET method, the pore volume being measured by a BJH method and an MP method.

  • ANALYSIS OF THE METHYLATION PATTERN OF THE ALPHA-SYNUCLEIN GENE FROM DNA OF PERIPHERAL BLOOD MONOCYTES FOR DIAGNOSING PARKINSON'S DISEASE

    A method of using peripheral blood monocytes of a patient to at least one of diagnose and assess a risk of a patient of developing Parkinson's disease includes obtaining peripheral blood monocytes from the patient, and determining a methylation pattern of the SNCA.sub.(-926/-483) region of the SNCA gene of the DNA of the peripheral blood monocytes.

  • BLOOD-CHEMISTRY IMBALANCE DETERMINATION BY MEANS OF REFLEX REACTION TIME MEASUREMENTS

    A system and method are provided whereby periodic measurements of autonomic reflex times of individuals are used as an early-warning indication that an undesirable physical condition, such as an undesirable blood-chemistry condition, may exist. This method correlates measurements of the reaction times of specific autonomic reflexes to more-definitive measurements for the medical condition being monitored for this early-warning assessment.

  • BLOOD TREATMENT SYSTEMS AND METHODS

    Dialysis systems comprising actuators that cooperate to perform dialysis functions and sensors that cooperate to monitor dialysis functions are disclosed. According to one aspect, such a hemodialysis system comprises a user interface model layer, a therapy layer, below the user interface model layer, and a machine layer below the therapy layer. The user interface model layer is configured to manage the state of a graphical user interface and receive inputs from a graphical user interface. The therapy layer is configured to run state machines that generate therapy commands based at least in part on the inputs from the graphical user interface. The machine layer is configured to provide commands for the actuators based on the therapy commands.

  • SYSTEM AND METHODS FOR MANAGING BLOOD LOSS OF A PATIENT

    One variation of the method for managing blood loss of a patient includes: receiving an image of a physical sample; extracting a feature from an area of the image corresponding to the physical sample; estimating a blood volume indicator of the physical sample according to the extracted feature; estimating a patient blood loss based on the blood volume indicator; estimating a euvolemic patient hematocrit based on an estimated patient blood volume and the estimated patient blood loss; receiving a measured patient hematocrit; and generating a volemic status indicator based on a comparison between the measured patient hematocrit and the estimated euvolemic patient hematocrit.

  • BLOOD VESSEL GRAFTS FOR REPAIR, RECONSTRUCTION AND FILLER MATERIALS

    Compositions comprising aortic material and methods for using harvested blood vessels (e.g., arteries or veins e.g., aortae) graft procedures, e.g., for restoring and repairing luminal structures (e.g., in the aerodigestive tract, such as the larynx, pharynx, and esophagus); as tissue fillers (e.g., injectable morselized blood vessel tissues, for use in cosmetic applications and functional sphincter enhancement); and as biological structural supports (e.g., intact portions of aortae, for use in repairing abdominal wounds, anastomoses, bony repairs, and the heart).

  • BLOOD VESSEL GRAFTS FOR REPAIR, RECONSTRUCTION AND FILLER MATERIALS

    Compositions comprising aortic material and methods for using harvested blood vessels (e.g., arteries or veins e.g., aortae) graft procedures, e.g., for restoring and repairing luminal structures (e.g., in the aerodigestive tract, such as the larynx, pharynx, and esophagus); as tissue fillers (e.g., injectable morselized blood vessel tissues, for use in cosmetic applications and functional sphincter enhancement); and as biological structural supports (e.g., intact portions of aortae, for use in repairing abdominal wounds, anastomoses, bony repairs, and the heart).

  • AGENT FOR INHIBITING ELEVATION IN BLOOD GLUCOSE LEVEL

    The present invention relates to a suppressor for increase in postprandial blood glucose level, which contains an ester of EPA or DHA as an active ingredient and is characterized by being administered between meals. The present invention provides a suppressor for increase in blood glucose level which is highly safe and has desired properties including storage stability, particularly a means for preventing postprandial hyperglycemia.

  • PORTABLE BLOOD PRESSURE MEASURING APPARATUS AND BLOOD PRESSURE MEASURING METHOD IN PORTABLE TERMINAL

    A method and apparatus for readily measuring a blood pressure without using a cuff includes measuring, by a portable blood pressure measuring apparatus, an electrocardiogram signal and a pulse wave signal, transmitting the measured electrocardiogram signal and pulse wave signal to a portable terminal, calculating, by the portable terminal, a Pulse Transit Time (PTT) and a Pulse Wave Velocity (PWV) using the transmitted electrocardiogram signal and the pulse wave signal, and calculating a blood pressure value based on the PTT and the PWV. Therefore, users may readily measure a blood pressure at any time and place and may be provided with a customized blood pressure measurement result.

  • METHOD FOR RESPIRATION RATE AND BLOOD PRESSURE ALARM MANAGEMENT

    Embodiments of the present disclosure relate to display features that facilitate observation of monitored physiological data. According to certain embodiments, a monitoring system may include a monitor capable of receiving data related to the physiological parameters and storing data related to the parameters. The monitor may include a microprocessor configured to determine a blood pressure baseline from the data and to establish an alarm sensitivity for blood pressure based on the blood pressure baseline. The alarm sensitivity may comprise a first tier, a second tier, a third tier, and a fourth tier, and each tier may correspond to a blood pressure range. The alarm sensitivity may relate to an acceptable percent shift of the blood pressure from the blood pressure baseline, and the acceptable percent shift for at least one of the tiers is different from the acceptable percent shift of another one of the tiers.

  • PYRIDONE AMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES

    Compounds useful in the treatment of mammalian cancers and especially human cancers according to Formula I are disclosed. ##STR00001## Pharmaceutical compositions and methods of treatment employing the compounds disclosed herein are also disclosed.